IMPACT OF EXPRESSION OF DRUG RESISTANCE GENES (ABCB1) ON THERAPEUTIC FAILURE IN ADULTS WITH ACUTE MYELOID LEUKEMIA

被引：0
|
作者：
Paredes, Y. [1 ]
Ramos Penafiel, C. O. [1 ]
Olarte, I. [1 ]
Figueroa Efreen, Montano H. [1 ]
Ceron Maldonado, R. [1 ]
Collazo Jaloma, J. [1 ]
Zazueta Pozos, J. F. [1 ]
Barranco Lampon, G. I. [1 ]
Martinez Tovar, A. [1 ]
机构：
[1] Hosp Gen Mexico Dr Eduardo Liceaga, Mexico City, DF, Mexico
来源：
HAEMATOLOGICA | 2018年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PC-185
引用
收藏
页码：203 / 204
页数：2
相关论文
共 50 条
  • [1] ABCB1 Expression in Acute Myeloid Leukemia (AML): A Possible Predictive Value for Treatment Resistance?
    Correa, Stephany
    Abdelhay, Eliana
    Paschka, Peter
    Gaidzik, Verena I.
    Hassan, Rocio
    Claus, Rainer
    Schlenk, Richard F.
    Doehner, Konstanze
    Bullinger, Lars
    BLOOD, 2014, 124 (21)
  • [2] Reversing multidrug resistance (MDR1, ABCB1) in acute myeloid leukemia: back to the ABCs
    Rund, Deborah
    LEUKEMIA & LYMPHOMA, 2013, 54 (11) : 2347 - 2348
  • [3] Clinical Significance of ABCB1 in Acute Myeloid Leukemia: A Comprehensive Study
    Boyer, Thomas
    Gonzales, Fanny
    Barthelemy, Adeline
    Marceau-Renaut, Alice
    Peyrouze, Pauline
    Guihard, Soizic
    Lepelley, Pascale
    Plesa, Adriana
    Nibourel, Olivier
    Delattre, Carole
    Wetterwald, Marc
    Pottier, Nicolas
    Plantier, Isabelle
    de Botton, Stephane
    Dombret, Herve
    Berthon, Celine
    Preudhomme, Claude
    Roumier, Christophe
    Cheok, Meyling
    CANCERS, 2019, 11 (09)
  • [4] ABCB1 as a potential beneficial target of midostaurin in acute myeloid leukemia
    Sucha, Simona
    Sorf, Ales
    Svoren, Martin
    Vagiannis, Dimitrios
    Ahmed, Fahda
    Visek, Benjamin
    Ceckova, Martina
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 150
  • [5] The temporal relationship between ABCB1 promoter hypomethylation, ABCB1 expression and acquisition of drug resistance
    Reed, K.
    Hembruff, S. L.
    Sprowl, J. A.
    Parissenti, A. M.
    PHARMACOGENOMICS JOURNAL, 2010, 10 (06): : 489 - 504
  • [6] The temporal relationship between ABCB1 promoter hypomethylation, ABCB1 expression and acquisition of drug resistance
    K Reed
    S L Hembruff
    J A Sprowl
    A M Parissenti
    The Pharmacogenomics Journal, 2010, 10 : 489 - 504
  • [7] Overexpression of the ABCB1 drug transporter in acute myeloid leukemia cells is associated with downregulation of latrophilin-1
    Kocibalova, Zuzana
    Guzyova, Martina
    Imrichova, Denisa
    Sulova, Zdena
    Breier, Albert
    GENERAL PHYSIOLOGY AND BIOPHYSICS, 2018, 37 (03) : 353 - 357
  • [8] ABCB1 AND DRUG RESISTANCE IN MEDULLOBLASTOMA
    Othman, Ramadhan T.
    Storer, Lisa
    Grundy, Richard
    Kerr, Ian
    Coyle, Beth
    NEURO-ONCOLOGY, 2012, 14 : 89 - 89
  • [9] ABCB1 and BMI1 mRNA expression in patients with chronic myeloid leukemia: impact on imatinib efficacy
    Bedewy, Ahmed M. L.
    Elmaghraby, Shereen M.
    Kandil, Noha S.
    BLOOD RESEARCH, 2019, 54 (01) : 57 - 62
  • [10] METFORMIN IMPROVES PROGNOSIS IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA THAT OVEREXPRESS THE DRUG RESISTANCE GENE ABCB1
    Ramos Penafiel, C. O.
    Olarte, I.
    Castellanos Sinco, H.
    Rozen, E.
    Collazo Jaloma, J.
    Martinez Tovar, A.
    Zazueta Pozos, J. F.
    Santoyo Sanchez, A.
    Ceron Maldonado, R.
    Barranco Lampon, G. I.
    HAEMATOLOGICA, 2018, 103 : 195 - 195
12345